Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > Any good reason Spectral can't run a trial?

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Apr 07, 2022 8:22pm

106 Views

Post# 34586413

RE:RE:RE:RE:Any good reason Spectral can't run a trial?

Zero to show for it? I'd say millions of options maybe?

They are a year or less away from 2 separate billion, or multi billion dollar FDA approvals that will make management extremely rich. Maybe sooner if they sell either or both assets.

Sounds pretty smart too me.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects